D-GalN/LPS administration also upregulated mRNA expression of several major inflammatory mediators in liver, including TNF-α, IL-6, IFNγ, and interleukin 1 beta (IL-1β); however, HPS treatment decreased the levels of these mediators (Figure 3B). The gene discussed is IL1B; the disease is Hermansky-Pudlak syndrome.